文档简介
1、 HYPERLINK https:/www.MedChemE/Targets/SGK.html SGKSerum-glucocorticoid regulated kinase; Serum and glucocorticoid-regulated kinaseSerum- and glucocorticoid-inducible kinases (SGKs) form a novel family of serine/threonine kinases that are activated in responseto a variety of extracellular stimuli. S
2、GK family contains three isoforms: SGK1, SGK2, and SGK3. The mRNA encoding SGK1, thebest-studied member of the SGK family, is rapidly induced in response to a variety of stimuli, including growth factors, steroid andpeptide hormones, cytokines, changes in cell volume, and brain injury.SGKs are relat
3、ed to Akt (also called PKB), a serine/threonine kinase that plays a crucial role in promoting cell survival. The SGKfamily members share similar structure, substrate specificity and function with AKT and signal downstream of thephosphatidylinositol 3-kinase (PI3K) signalling pathway. They regulate a
4、 range of fundamental cellular processes such as cellproliferation and survival, thereby playing an important role in cancer development. In addition, SGKs not only regulate cellproliferation and survival, but also play important roles in cancer development via an AKT-independent signalling pathway.
5、 Theimportance of SGKs in cancer development and the scarcity of potent and selective SGK inhibitors support the urgent need fordiscovery and development of small molecules inhibitors targeting SGK for PIK3CA mutant cancers, and especially those that areresistant to AKT inhibition.www.MedChemE 1 HYP
6、ERLINK https:/www.MedChemE/Targets/SGK.html SGK HYPERLINK https:/www.MedChemE/Targets/SGK.html HYPERLINK https:/www.MedChemE/Targets/SGK.html Inhibitors HYPERLINK https:/www.MedChemE/cki7.html CKI-7 HYPERLINK https:/www.MedChemE/cki7.html HYPERLINK https:/www.MedChemE/cki-7.html CKI-7 HYPERLINK http
7、s:/www.MedChemE/cki-7.html HYPERLINK https:/www.MedChemE/cki-7.html free HYPERLINK https:/www.MedChemE/cki-7.html HYPERLINK https:/www.MedChemE/cki-7.html baseCat. No.: HY-W011109 Cat. No.: HY-133028CKI-7 is a potent and ATP-competitive casein kinase1 (CK1) ICinhibitor with an 50 of 6 M and a Kiof 8
8、.5 M. CKI-7 is a selective Cdc7 kinaseinhibitor. CKI-7 also inhibits SGK, ribosomalS6 kinase-1 (S6K1) and mitogen- andstress-activated protein kinase-1 (MSK1).CKI-7 free base is a potent and ATP-competitivecasein kinase 1 (CK1) inhibitor with an IC of 650M and a K of 8.5 M. CKI-7 free base is aisele
9、ctive Cdc7 kinase inhibitor.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.31%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/EMD638683.html EMD638683 HYPERLINK https:/www.MedChemE/EMD638683.html HYP
10、ERLINK https:/www.MedChemE/EMD638683-R-Form.html EMD638683 HYPERLINK https:/www.MedChemE/EMD638683-R-Form.html HYPERLINK https:/www.MedChemE/EMD638683-R-Form.html R-FormCat. No.: HY-15193 Cat. No.: HY-15193AEMD638683 is a highly selective SGK1 inhibitor,with an IC value of 3 M.50EMD638683 R-Form is
11、the R-form of EMD638683.EMD638683 is a highly selective SGK1 inhibitorwith IC of 3 M.50Purity: 99.80%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.68%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www
12、.MedChemE/EMD638683-S-Form.html EMD638683 HYPERLINK https:/www.MedChemE/EMD638683-S-Form.html HYPERLINK https:/www.MedChemE/EMD638683-S-Form.html S-Form HYPERLINK https:/www.MedChemE/EMD638683-S-Form.html HYPERLINK https:/www.MedChemE/GSK-650394.html GSK HYPERLINK https:/www.MedChemE/GSK-650394.html
13、 HYPERLINK https:/www.MedChemE/GSK-650394.html 650394Cat. No.: HY-15193B Cat. No.: HY-15192EMD638683 S-Form is the S-form of EMD638683.EMD638683 is a highly selective SGK1 inhibitorwith IC of 3 M.50GSK 650394 is a novel SGK inhibitor with IC of5062 nM and 103 nM for SGK1 and SGK2 in the SPAassay res
14、pectively. GSK 650394 also inhibitsinfluenza virus replication.Purity: 99.95%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.76%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/hu7691.html Hu7691 HYP
15、ERLINK https:/www.MedChemE/hu7691.html HYPERLINK https:/www.MedChemE/hu7691-free-base.html Hu7691 HYPERLINK https:/www.MedChemE/hu7691-free-base.html HYPERLINK https:/www.MedChemE/hu7691-free-base.html free HYPERLINK https:/www.MedChemE/hu7691-free-base.html HYPERLINK https:/www.MedChemE/hu7691-free
16、-base.html baseCat. No.: HY-132302 Cat. No.: HY-132302AHu7691 is an orally active, selective Aktinhibitor with IC s of 4.0 nM, 97.5 nM, 28 nM for50Akt1, Akt2 and Akt3, respectively. Hu7691 inhibitstumor growth and enables decrease of cutaneoustoxicity in mice.Hu7691 free base is an orally active, se
17、lectiveAkt inhibitor with IC s of 4.0 nM, 97.5 nM, 2850nM for Akt1, Akt2 and Akt3, respectively. Hu7691free base inhibits tumor growth and enablesdecrease of cutaneous toxicity in mice.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedS
18、ize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/pf-4950834.html PF-4950834 HYPERLINK https:/www.MedChemE/pf-4950834.html HYPERLINK https:/www.MedChemE/protac-sgk3-degrader-1.html PROTAC HYPERLINK https:/www.MedChemE/protac-sgk3-degrader-1.html HYPERLINK https:/www.MedChemE/protac-sgk3-degrader-1.html
19、SGK3 HYPERLINK https:/www.MedChemE/protac-sgk3-degrader-1.html HYPERLINK https:/www.MedChemE/protac-sgk3-degrader-1.html degrader-1Cat. No.: HY-122011(SGK3-PROTAC1) Cat. No.: HY-125878PF-4950834 is a potent, selective, orallybioavailable, ATP-competitive rho kinase inhibitorwith IC values of 8.35 nM
20、 and 33.12 nM against50ROCK2 and ROCK1, respectively. PF-4950834 inhibitsneutrophil migration.PROTAC SGK3 degrader-1 (SGK3-PROTAC1), is a potentSKG3 degrader based on von Hippel-Lindau ligand.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.32%Clinical Data: No Development
21、 ReportedSize: 1 mg, 5 mg, 10 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/SGK1-IN-1.html SGK1-IN-1 HYPERLINK https:/www.MedChemE/SGK1-IN-1.html HYPERLINK https:/www.MedChemE/sgk1-in-2.html SGK1-IN-2Cat. No.: HY-18607 Cat. No.: HY-135893SGK1-IN-1 is a highly active and selectiveinhibitor of SGK-1, with an IC of 1 nM.50SGK1-IN-2 (14h) is a selective SGK1 (serum andglucocorticoid regulated kinase 1) inhibitor,with an IC of 5 nM at 10 M ATP concentration.50Purity: 98.76%Cli
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025年度木结构建筑设计与施工总承包合同8篇
- 国际贸易课件:WTO的反倾销制度
- 2025年度数据中心承建与信息安全防护合同4篇
- 二零二五年度LED显示屏产品安全认证合同3篇
- 2025版环保设施运营维护管理承包合同范本4篇
- 2025年度木材市场风险管理与价格波动合同4篇
- 二零二五年度养老产业项目合伙人分红及服务质量保障合同
- 二零二五年度池塘水域渔业养殖技术培训与推广协议
- 2025年度企业销售团队绩效目标协议书
- 二零二五年度顺丰快递员劳动合同争议解决机制
- 2024生态环境相关法律法规考试试题
- 有砟轨道施工工艺课件
- 两办意见八硬措施煤矿安全生产条例宣贯学习课件
- 40篇短文搞定高中英语3500单词
- 人教版高中数学必修二《第九章 统计》同步练习及答案解析
- 儿科护理安全警示教育课件
- 三年级下册口算天天100题
- 国家中英文名称及代码缩写(三位)
- 人员密集场所消防安全培训
- 液晶高压芯片去保护方法
- 拜太岁科仪文档
评论
0/150
提交评论